pharma · Hypertension · Breast Neoplasms
Pfizer
Pfizer clinical programs — 12 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- New York 10017, US
- Employees
- 103,316
- Programs
- 98
- Drugs
- 80
- Patents
- 0
Pfizer projects
12 ClinicalTrials.gov programs sponsored by Pfizer.
Pfizer has 12 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AG-013736
Pfizer
Thyroid Neoplasms
1 trial -
CE-326,597 100 mg QD
Pfizer
Weight Management
1 trial -
Maraviroc
Pfizer
Arthritis, Rheumatoid
1 trial -
PD 0332991
Pfizer
Breast Cancer
1 trial -
PF-03446962
Pfizer
Carcinoma, Hepatocellular
1 trial -
PF-04236921 SC injection
Pfizer
Crohn's Disease
1 trial -
PF-06650833
Pfizer
Rheumatoid Arthritis
1 trial -
PF-06835375
Pfizer
Primary Immune Thrombocytopenia
1 trial -
PH-797804
Pfizer
Pulmonary Disease, Chronic Obstructive
1 trial -
Sasanlimab Prefilled syringe
Pfizer
Carcinoma, Non-Small-Cell Lung
1 trial -
UK-453,061 Dose 1
Pfizer
HIV-1
1 trial -
disitamab vedotin
Pfizer
Urothelial Carcinoma
1 trial
Frequently asked questions
How many clinical projects does Pfizer have?
12 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.